Procyon Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
58,696
-19,895
| -25% | -$482K | 0.13% | 143 |
|
|
2025
Q1 | $1.95M | Buy |
78,591
+23,020
| +41% | +$572K | 0.12% | 174 |
|
|
2024
Q4 | $1.47M | Sell |
55,571
-576
| -1% | -$15.3K | 0.09% | 199 |
|
|
2024
Q3 | $1.63M | Buy |
56,147
+329
| +0.6% | +$9.52K | 0.11% | 184 |
|
|
2024
Q2 | $1.56M | Sell |
55,818
-3,182
| -5% | -$89K | 0.12% | 176 |
|
|
2024
Q1 | $1.64M | Sell |
59,000
-3,111
| -5% | -$86.3K | 0.13% | 175 |
|
|
2023
Q4 | $1.79M | Sell |
62,111
-16,524
| -21% | -$476K | 0.15% | 154 |
|
|
2023
Q3 | $2.61M | Buy |
78,635
+33,196
| +73% | +$1.1M | 0.27% | 93 |
|
|
2023
Q2 | $1.67M | Buy |
45,439
+14,553
| +47% | +$534K | 0.21% | 109 |
|
|
2023
Q1 | $1.26M | Buy |
30,886
+2,572
| +9% | +$105K | 0.21% | 114 |
|
|
2022
Q4 | $1.45M | Buy |
28,314
+5,464
| +24% | +$280K | 0.27% | 87 |
|
|
2022
Q3 | $1M | Sell |
22,850
-1,939
| -8% | -$84.9K | 0.24% | 94 |
|
|
2022
Q2 | $1.3M | Sell |
24,789
-2,929
| -11% | -$154K | 0.29% | 84 |
|
|
2022
Q1 | $1.44M | Buy |
27,718
+325
| +1% | +$16.8K | 0.3% | 74 |
|
|
2021
Q4 | $1.62M | Sell |
27,393
-2,457
| -8% | -$145K | 0.34% | 67 |
|
|
2021
Q3 | $1.28M | Sell |
29,850
-8,688
| -23% | -$374K | 0.33% | 73 |
|
|
2021
Q2 | $1.51M | Buy |
38,538
+22,936
| +147% | +$898K | 0.41% | 62 |
|
|
2021
Q1 | $565K | Sell |
15,602
-210
| -1% | -$7.61K | 0.25% | 90 |
|
|
2020
Q4 | $582K | Buy |
15,812
+1,384
| +10% | +$50.9K | 0.28% | 86 |
|
|
2020
Q3 | $502K | Buy |
14,428
+1,966
| +16% | +$68.4K | 0.28% | 87 |
|
|
2020
Q2 | $387K | Buy |
12,462
+1,497
| +14% | +$46.5K | 0.21% | 102 |
|
|
2020
Q1 | $340K | Sell |
10,965
-1,058
| -9% | -$32.8K | 0.23% | 92 |
|
|
2019
Q4 | $447K | Buy |
+12,023
| New | +$447K | 0.27% | 85 |
|